Leerink Swann reaffirmed their outperform rating on shares of Walgreens Boots Alliance Inc. (NASDAQ:WBA) in a report issued on Monday morning. They currently have a $95.00 price objective on the pharmacy operator’s stock.

WBA has been the topic of several other research reports. Robert W. Baird reissued an outperform rating and set a $98.00 price objective on shares of Walgreens Boots Alliance in a research note on Monday, June 27th. Evercore ISI reissued a buy rating and set a $93.00 price objective on shares of Walgreens Boots Alliance in a research note on Thursday, July 7th. Zacks Investment Research raised shares of Walgreens Boots Alliance from a sell rating to a hold rating in a research note on Tuesday, June 21st. Credit Suisse Group AG reissued an outperform rating and set a $95.00 price objective (up previously from $80.71) on shares of Walgreens Boots Alliance in a research note on Thursday, September 1st. Finally, Deutsche Bank AG reissued a buy rating on shares of Walgreens Boots Alliance in a research note on Monday, July 18th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the company’s stock. The stock currently has a consensus rating of Buy and an average target price of $93.13.

Walgreens Boots Alliance (NASDAQ:WBA) opened at 82.38 on Monday. The firm has a 50 day moving average of $81.79 and a 200 day moving average of $81.27. The firm has a market cap of $89.16 billion, a P/E ratio of 28.47 and a beta of 1.01. Walgreens Boots Alliance has a 1-year low of $71.50 and a 1-year high of $95.74.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Wednesday, July 6th. The pharmacy operator reported $1.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.14 by $0.04. Walgreens Boots Alliance had a net margin of 2.70% and a return on equity of 15.56%. The company had revenue of $29.50 billion for the quarter. During the same period last year, the company earned $1.02 EPS. The firm’s revenue for the quarter was up 2.4% on a year-over-year basis. On average, equities research analysts expect that Walgreens Boots Alliance will post $4.51 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Monday, September 12th. Stockholders of record on Friday, August 19th were paid a $0.375 dividend. The ex-dividend date was Wednesday, August 17th. This represents a $1.50 annualized dividend and a dividend yield of 1.82%. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.36. Walgreens Boots Alliance’s payout ratio is currently 51.90%.

In other news, EVP Kathleen Wilson-Thompson sold 29,695 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, July 14th. The shares were sold at an average price of $83.00, for a total value of $2,464,685.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director William C. Foote sold 2,067 shares of Walgreens Boots Alliance stock in a transaction that occurred on Tuesday, July 26th. The stock was sold at an average price of $81.35, for a total transaction of $168,150.45. Following the completion of the transaction, the director now directly owns 26,690 shares in the company, valued at $2,171,231.50. The disclosure for this sale can be found here. 21.10% of the stock is currently owned by insiders.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Fisher Asset Management LLC boosted its stake in Walgreens Boots Alliance by 30.3% in the first quarter. Fisher Asset Management LLC now owns 7,343 shares of the pharmacy operator’s stock worth $598,000 after buying an additional 1,708 shares during the period. Nicolet Bankshares Inc. boosted its stake in Walgreens Boots Alliance by 19.7% in the first quarter. Nicolet Bankshares Inc. now owns 4,867 shares of the pharmacy operator’s stock worth $410,000 after buying an additional 800 shares during the period. CrestPoint Capital Management LLC boosted its stake in Walgreens Boots Alliance by 95.8% in the first quarter. CrestPoint Capital Management LLC now owns 18,800 shares of the pharmacy operator’s stock worth $1,584,000 after buying an additional 9,200 shares during the period. Koshinski Asset Management Inc. boosted its stake in Walgreens Boots Alliance by 22.8% in the first quarter. Koshinski Asset Management Inc. now owns 7,863 shares of the pharmacy operator’s stock worth $667,000 after buying an additional 1,461 shares during the period. Finally, TNB Financial acquired a new stake in Walgreens Boots Alliance during the first quarter worth about $319,000. 59.74% of the stock is currently owned by institutional investors and hedge funds.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

5 Day Chart for NASDAQ:WBA

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.